Loading
Ypsomed Holding AG Stock: price and insider trades · Switzerland
No insider purchase over the last 90 days. The latest was filed 08 Dec 2025.
Ypsomed Holding AG: what insiders have been doing
Headquartered in Burgdorf, Switzerland, Ypsomed Holding AG belongs to the Health Care sector and traces its origins to 2003. Filings by its managers are published through SIX SER. Over the twelve months to 18 October 2026, 6 filings were filed, from 3 insiders.
On the market, 1 insider bought (3 purchases totalling €88k) while 3 insiders sold (3 sales totalling €822k). The net balance comes to €735k on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. On the buying side, the filings list 1 senior executive among the declarants. One trade stands out by size: a sale of €391k, disclosed on 6 July 2026, or 0.0078% of market capitalisation.
Compared with its exchange (178 companies, median 9 filings), a count of 6 filings is below the norm. Our records for Ypsomed Holding AG go back to 2023, with 7 purchases and 9 sales on the open market in total.
The latest purchase dates back some time: it was published 314 days ago, on 8 December 2025. Publication is fast: at least half of the trades appear on SIX SER on the same day. The shorter that gap, the sooner other investors can see what insiders have done.
In the same sector, recent insider purchases at Cooper Companies, Inc. and Anixa Biosciences Inc also feature in our signals. This summary is built from SIX SER disclosures alone and does not predict where the share price will go.
Insider Decl.
16
Thresholds
n/a
Buy Volume
€325,881
7 ops. · all time
Sell Volume
€1M
9 ops. · all time
Who traded when
BuySaleAnonymous (Executive member of the board of directors / member of senior management)5 buys3 sales
Anonymous (a non-executive member of the board of directors)1 sale
Anonymous (an executive member of the board of directors / member of senior management)1 sale
Since the insiders bought
- Anonymous (Executive member of the board of directors / member of senior management)-15.9%Entry CHF 328.00 · Close at T+90 CHF 276.00
- Anonymous (Non-executive member of the board of directors)-17.9%Entry CHF 383.50 · Close at T+365 CHF 315.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Ypsomed Holding AG Buy (bullish), based on 14 analysts. Average price target: CHF 398.64.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 6,905 of 24,148 companies
62.2
score / 100
Value44
Quality80
FCF yld-0.3%
Earn yld4.6%
EV/EBITDA15.6x
ROE31%
Gross mgn43%
Net mgn30%
Debt/EBITDA0.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
CHF 367.60
Analyst consensus
14 analystsBuy
CHF 280.00Target CHF 398.64(+8%)CHF 480.00
Income statement
RevenueCHF 731M
Gross profitCHF 314.6M43% margin
EBITDACHF 326.4M45% margin
Net incomeCHF 221.9M30.4% margin
Valuation
PER (trailing)22.6x
PER (forward)25.1x
P/Book6.5x
Beta0.81
Balance sheet & cash
Market capCHF 4.8B
Total debtCHF 260.8M
Free Cash Flow-CHF 16.3M
Debt / Equity35%
Profitability & ownership
ROE31.1%
ROA12.4%
% insiders69.6%
% institutions15.5%
Last declaration on 24 July 2026
Declarations16 total
100 shares@ CHF 370.000.0008% mcap100.0% of flowSIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q7O00078
▼
Anonymous (an executive member of the board of directors / member of senior management)
1,000 shares@ CHF 360.000.0078% mcap100.0% of flowSIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q7600018
▼
Anonymous (Executive member of the board of directors / member of senior management)
1,000 shares@ CHF 360.000.0078% mcap32.1% of flowISIN CH0019396990SIX:T1Q7600018
▲
Anonymous (Executive member of the board of directors / member of senior management)
105 shares@ CHF 274.252.5% of flowISIN CH0019396990SIX:T1PC800081
Canonical exit: 8 Mar 2026 (T+90)
▲
Anonymous (Executive member of the board of directors / member of senior management)
98 shares@ CHF 274.252.4% of flowISIN CH0019396990SIX:T1PC8000A8
Canonical exit: 8 Mar 2026 (T+90)
▲
Anonymous (Executive member of the board of directors / member of senior management)
96 shares@ CHF 274.252.3% of flowISIN CH0019396990SIX:T1PC800099
Canonical exit: 8 Mar 2026 (T+90)
▲
Anonymous (Executive member of the board of directors / member of senior management)
45 shares@ CHF 351.501.4% of flowISIN CH0019396990SIX:T1P9O00026
Canonical exit: 23 Dec 2025 (T+90)
▲
Anonymous (Executive member of the board of directors / member of senior management)
55 shares@ CHF 363.001.8% of flowISIN CH0019396990SIX:T1P9N000D9
Canonical exit: 22 Dec 2025 (T+90)
▼
Anonymous (Executive member of the board of directors / member of senior management)
200 shares@ CHF 417.007.3% of flowISIN CH0019396990SIX:T1P7A00011
▼
Anonymous (Executive member of the board of directors / member of senior management)
100 shares@ CHF 405.003.6% of flowISIN CH0019396990SIX:T1P5U000B8
▲
Anonymous (Executive member of the board of directors / member of senior management)
350 shares@ CHF 416.0012.7% of flowISIN CH0019396990SIX:T1O9U00016
Canonical exit: 29 Dec 2024 (T+90)
▼
Anonymous (Executive member of the board of directors / member of senior management)
296 shares@ CHF 437.0011.2% of flowISIN CH0019396990SIX:T1O9Q00097
100 shares@ CHF 427.76100.0% of flowISIN CH0019396990SIX:T1O9O000A7
Canonical exit: 23 Dec 2024 (T+90)
▼
Anonymous (Executive member of the board of directors / member of senior management)
200 shares@ CHF 390.006.5% of flowISIN CH0019396990SIX:T1O5R000D2
▼
Anonymous (Executive member of the board of directors / member of senior management)
400 shares@ CHF 385.0012.8% of flowISIN CH0019396990SIX:T1O5M00037
▼
Anonymous (Executive member of the board of directors / member of senior management)
150 shares@ CHF 272.000.0007% mcap3.5% of flowISIN CH0019396990SIX:T1N9T00027
16 of 16 declarations
About Ypsomed Holding AG
Ypsomed Holding AG is a Swiss company that specializes in the development and manufacturing of drug delivery systems, particularly injection devices. It focuses on solutions for diabetes and other chronic diseases.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
